Deal Details

Initial Public Offering

Healthcare

Initial Public Offering

Summary

Baird served as a book-running manager on this offering

About

Envista Holdings Corporation (“Envista” or the “Company”) (NYSE:NVST), a subsidiary of Danaher Corporation (“Danaher”) (NYSE:DHR), recently completed an initial public offering of 30,783,200 shares of its common stock at a public offering price of $22.00 per share, which includes the exercise in full by the underwriters of their option to purchase an additional 4,015,200 shares of common stock. The gross proceeds from the offering, before deducting underwriting discounts and commissions, are $667.23 million. As of the closing of the IPO, Danaher holds approximately 80.6% of Envista.

Envista is a global dental products company that develops and provides a comprehensive portfolio of dental consumables, equipment and services to dental professionals covering an estimated 90% of dentists’ clinical needs for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. Envista’s operating companies, Nobel Biocare Systems, Ormco and KaVo Kerr, serve more than one million dentists in over 150 countries. Envista is headquartered in Brea, California.

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life’s Potential. Danaher is headquartered in Washington, the District of Columbia.

Healthcare

Initial Public Offering